The cost of Invega Trinza can vary significantly depending on factors such as dosage, insurance coverage, pharmacy, and geographic location. A 3-month supply of Invega Trinza (paliperidone palmitate) 175 mg/0.75 mL injection may cost around $4,700 to $5,000 without insurance [1]. Some sources indicate a price closer to $4,900 for this dosage [1].
What does Invega Trinza treat?
Invega Trinza is a long-acting injectable antipsychotic used for the treatment of schizophrenia in adults [2]. It is also used for the maintenance treatment of schizoaffective disorder in adults [2]. The medication is administered by a healthcare professional every three months [2].
How can I reduce the cost of Invega Trinza?
For eligible patients, there are manufacturer-provided savings programs that can help reduce out-of-pocket costs. For example, the Invega Sustenna & Trinza Savings Program may offer as little as a $10 co-pay for eligible commercially insured patients [3]. Eligibility requirements apply, and these programs often have monthly or annual limits. Information on such programs is typically available through the drug manufacturer's website or directly from a pharmacy.
How does Invega Trinza work?
Invega Trinza is a long-acting injectable formulation of paliperidone palmitate [2]. Paliperidone is an atypical antipsychotic that works by affecting the activity of dopamine and serotonin in the brain [2]. These neurotransmitters are involved in regulating mood, thought, and behavior. By influencing these systems, Invega Trinza helps to manage the symptoms of schizophrenia and schizoaffective disorder.
When does Invega Trinza's patent expire?
The patent landscape for Invega Trinza and its active ingredient, paliperidone, is complex and involves multiple patents covering the formulation, manufacturing process, and methods of use. Pharmaceutical patents typically last for 20 years from the filing date, but various extensions and exclusivities can apply [4]. Information regarding specific patent expiration dates for Invega Trinza can be found on resources like DrugPatentWatch.com [5]. Generally, once patents expire and any relevant exclusivities lapse, generic versions of the drug can become available, which often leads to lower prices.
Are there alternatives to Invega Trinza?
Yes, there are other long-acting injectable antipsychotics available for the treatment of schizophrenia and schizoaffective disorder. These include other formulations of paliperidone (e.g., Invega Sustenna) and medications containing different active ingredients such as aripiprazole, risperidone, olanzapine, and haloperidol [6]. The choice of alternative depends on individual patient needs, medical history, and physician recommendations.
Sources:
[1] GoodRx, Invega Trinza Price, https://www.goodrx.com/invega-trinza
[2] U.S. Food and Drug Administration, Invega Trinza Prescribing Information, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020450s015lbl.pdf
[3] Invega Sustenna & Trinza Savings Program, https://www.invegasustennatrinza.com/savings-and-support/
[4] U.S. Food and Drug Administration, Patent Term Restoration and Extension, https://www.fda.gov/drugs/patent-and-exclusivity/patent-term-restoration-and-extension
[5] DrugPatentWatch.com
[6] National Alliance on Mental Illness, Long-Acting Injectable Medications, https://www.nami.org/About-Mental-Illness/Treatments/Psychiatric-Medications/Long-Acting-Injectable-Medications